360
Participants
Start Date
July 28, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
ET
Empirical therapy Based on drug history: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin triple/quadruple therapy or concomitant therapy
SGT
Susceptibility testing guided therapy Based on susceptibility test: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin triple/quadruple therapy or concomitant therapy
RECRUITING
National Taiwan University Hospital, Taipei
National Taiwan University Hospital
OTHER